Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 218375

In scope icon N/A
QID 218375 (Type "218375" in App Search)
A 34-year-old man is brought to the emergency department by ambulance after being found down in a city park. He is somnolent and complains of diarrhea. A review of the medical record shows that he has a history of hypertension, hyperlipidemia, alcohol dependence, opiate dependence, and tobacco use. He has no surgical history. He is homeless and has multiple prior emergency department visits for alcohol intoxication. Per his chart, he drinks 1 liter of vodka every day. His last drink was earlier today. He also uses fentanyl and his last use was yesterday. The patient’s temperature is 98.6°F (37.0°C), blood pressure is 130/70 mmHg, pulse is 70/min, and respirations are 18/min. On physical examination, the patient appears disheveled and his breath has a strong alcohol odor. His pupils measure 4 mm bilaterally. The patient is tremulous and anxious. A computed tomography scan of the head is negative for intracranial hemorrhage. He is given lorazepam and buprenorphine for his condition. One hour later, he experiences lacrimation, piloerection, and vomiting. He yawns frequently. His tremors have resolved. Which of the following is the most likely cause of his current symptoms?

Alcohol withdrawal

0%

0/0

Anticholinergic toxicity

0%

0/0

Benzodiazepine overdose

0%

0/0

Buprenorphine administration

0%

0/0

Delirium tremens

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient presenting with early signs of alcohol withdrawal (tremulousness, anxiety) and mild opiate withdrawal (diarrhea) is given lorazepam for alcohol withdrawal and buprenorphine for opiate withdrawal. Buprenorphine administration can induce opiate withdrawal, presenting as lacrimation, piloerection, and vomiting.

Buprenorphine is a partial agonist at the mu opioid receptor with a strong affinity for the receptor. Therefore, buprenorphine will bind to and displace other opioids from the receptor. Because of its partial agonist effect, it will activate the opioid receptor below the effect seen with full agonists such as methadone. As such, buprenorphine can induce opioid withdrawal in patients after its administration. Opioid withdrawal presents with lacrimation, rhinorrhea, piloerection, myalgias, diarrhea, nausea, vomiting, mydriasis, and yawning. Buprenorphine is often used in the treatment of opioid dependence because it activates the mu opioid receptor with a lower likelihood of causing fatal respiratory depression. Other treatments for opioid dependence include methadone, a full mu opioid receptor agonist, and naltrexone, an antagonist of the mu opioid receptor.

Fareed et al. studied the effect of buprenorphine dosing on treatment outcomes for opioid dependence. The authors found that higher buprenorphine doses (16-32 mg/day) resulted in greater efficacy than lower doses (<16 mg/day). The authors recommended that higher buprenorphine doses be used in maintenance treatment for opioid dependence to improve efficacy.

Incorrect Answers:
Answer 1: Alcohol withdrawal presents with anxiety, restlessness, diaphoresis, and tremulousness. Moderate or severe withdrawal may present with hallucinations or seizures. Alcohol withdrawal can be life-threatening and should be treated with benzodiazepines. Thiamine supplementation should be initiated prior to glucose administration to prevent Wernicke encephalopathy. In contrast, yawning is specific for opiate withdrawal.

Answer 2: Anticholinergic toxicity presents with hyperthermia, altered mental status, tachycardia, flushing, dry mouth, constipation, urinary retention, and dry eyes. Common medications with anticholinergic side effects include antipsychotics, tricyclic antidepressants, and diphenhydramine. Neither lorazepam nor buprenorphine have anticholinergic effects.

Answer 3: Benzodiazepine overdose presents with somnolence, amnesia, and respiratory depression. Benzodiazepine overdose is treated conservatively, as the effects will wear off. Benzodiazepine overdose is unlikely in the setting of supervised administration for alcohol withdrawal, as medication administration and dosage is protocolized.

Answer 5: Delirium tremens is a severe form of alcohol withdrawal characterized by altered mental status, agitation, tachycardia, hypertension, fever, and diaphoresis. Delirium tremens occurs 48-96 hours after last alcohol intake and is life-threatening. Treatment is with benzodiazepines.

Bullet Summary:
Buprenorphine is a partial mu opioid receptor agonist with strong affinity for the receptor and can displace full opioid agonists, leading to opiate withdrawal.

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options